Vor Biopharma Inc.
VOR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$116,914 | -$117,863 | -$92,094 | -$68,899 |
| Dep. & Amort. | $3,528 | $3,492 | $2,525 | $1,434 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $9,847 | $13,362 | $10,695 | $4,315 |
| Change in WC | $5 | $650 | -$12,693 | -$9,185 |
| Other Non-Cash | $3,874 | $67 | $6,423 | $3,191 |
| Operating Cash Flow | -$99,660 | -$100,292 | -$85,144 | -$69,144 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$229 | -$1,069 | -$8,462 | -$3,894 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$9,914 | -$74,923 | -$123,189 | -$87,757 |
| Inv. Sales/Matur. | $107,000 | $147,000 | $37,560 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $96,857 | $71,008 | -$94,091 | -$91,651 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $55,825 | $4,578 | $115,975 | $189,198 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2,433 | -$1,640 | $1,165 | $43,713 |
| Financing Cash Flow | $53,392 | $2,938 | $117,140 | $232,911 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $50,589 | -$26,346 | -$62,095 | $72,116 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $33,773 | $60,119 | $122,214 | $50,098 |
| End Cash | $84,362 | $33,773 | $60,119 | $122,214 |
| Free Cash Flow | -$99,889 | -$101,361 | -$93,606 | -$73,038 |